136 related articles for article (PubMed ID: 20674451)
1. Fibromyalgia syndrome: prevalence, pharmacological and non-pharmacological interventions in outpatient health care. An analysis of statutory health insurance data.
Sauer K; Kemper C; Glaeske G
Joint Bone Spine; 2011 Jan; 78(1):80-4. PubMed ID: 20674451
[TBL] [Abstract][Full Text] [Related]
2. [Treatment and healthcare costs of fibromyalgia syndrome in Germany: analysis of the data of the Barmer health insurance (BEK) from 2008-2009].
Marschall U; Arnold B; Häuser W
Schmerz; 2011 Aug; 25(4):402-4, 406-10. PubMed ID: 21818719
[TBL] [Abstract][Full Text] [Related]
3. Patient-related predictors of treatment satisfaction of patients with fibromyalgia syndrome: results of a cross-sectional survey.
Lauche R; Häuser W; Jung E; Erbslöh-Möller B; Gesmann M; Kühn-Becker H; Petermann F; Weiss T; Thoma R; Winkelmann A; Langhorst J
Clin Exp Rheumatol; 2013; 31(6 Suppl 79):S34-40. PubMed ID: 23710561
[TBL] [Abstract][Full Text] [Related]
4. Individuals with fibromyalgia and depression: findings from a nationally representative Canadian survey.
Fuller-Thomson E; Nimigon-Young J; Brennenstuhl S
Rheumatol Int; 2012 Apr; 32(4):853-62. PubMed ID: 21221590
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and overlap of somatic symptom disorder, bodily distress syndrome and fibromyalgia syndrome in the German general population: A cross sectional study.
Häuser W; Hausteiner-Wiehle C; Henningsen P; Brähler E; Schmalbach B; Wolfe F
J Psychosom Res; 2020 Jun; 133():110111. PubMed ID: 32305723
[TBL] [Abstract][Full Text] [Related]
6. Fibromyalgia comorbidity in primary headaches.
de Tommaso M; Sardaro M; Serpino C; Costantini F; Vecchio E; Prudenzano MP; Lamberti P; Livrea P
Cephalalgia; 2009 Apr; 29(4):453-64. PubMed ID: 19170692
[TBL] [Abstract][Full Text] [Related]
7. [Diagnosis and therapy of fibromyalgia syndrome].
Köllner V; Bernardy K; Sommer C; Häuser W
Dtsch Med Wochenschr; 2009 May; 134(22):1163-74; quiz 1175-6. PubMed ID: 19603382
[TBL] [Abstract][Full Text] [Related]
8. Fibromyalgia syndrome: assessment of the severity of the condition 2 years after diagnosis.
Granges G; Zilko P; Littlejohn GO
J Rheumatol; 1994 Mar; 21(3):523-9. PubMed ID: 8006897
[TBL] [Abstract][Full Text] [Related]
9. Comorbid depression and anxiety in fibromyalgia syndrome: relationship to somatic and psychosocial variables.
Thieme K; Turk DC; Flor H
Psychosom Med; 2004; 66(6):837-44. PubMed ID: 15564347
[TBL] [Abstract][Full Text] [Related]
10. Comorbidity of fibromyalgia and cervical myofascial pain syndrome.
Cakit BD; Taskin S; Nacir B; Unlu I; Genc H; Erdem HR
Clin Rheumatol; 2010 Apr; 29(4):405-11. PubMed ID: 20066449
[TBL] [Abstract][Full Text] [Related]
11. The association between overactive bladder and fibromyalgia syndrome: a community survey.
Chung JH; Kim SA; Choi BY; Lee HS; Lee SW; Kim YT; Lee TY; Moon HS
Neurourol Urodyn; 2013 Jan; 32(1):66-9. PubMed ID: 22674758
[TBL] [Abstract][Full Text] [Related]
12. Clinical and economic characteristics of patients with fibromyalgia syndrome.
Lachaine J; Beauchemin C; Landry PA
Clin J Pain; 2010 May; 26(4):284-90. PubMed ID: 20393262
[TBL] [Abstract][Full Text] [Related]
13. Familial aggregation in the fibromyalgia syndrome.
Buskila D; Neumann L; Hazanov I; Carmi R
Semin Arthritis Rheum; 1996 Dec; 26(3):605-11. PubMed ID: 8989805
[TBL] [Abstract][Full Text] [Related]
14. [Are members of fibromyalgia syndrome self-help groups "different"? Demographic and clinical characteristics of members and non-members of fibromyalgia syndrome self-help groups].
Jung E; Erbslöh-Möller B; Gesmann M; Kühn-Becker H; Petermann F; Langhorst J; Weiss T; Thoma R; Winkelmann A; Häuser W
Z Rheumatol; 2013 Jun; 72(5):474-81. PubMed ID: 23579856
[TBL] [Abstract][Full Text] [Related]
15. [Fibromyalgia syndrome: Basic knowledge, diagnosis and treatment].
Häuser W
Med Monatsschr Pharm; 2016 Dec; 39(12):504-11. PubMed ID: 29979510
[TBL] [Abstract][Full Text] [Related]
16. Impact of IPDE-SQ personality disorders on the healthcare and societal costs of fibromyalgia patients: a cross-sectional study.
Gumà-Uriel L; Peñarrubia-María MT; Cerdà-Lafont M; Cunillera-Puertolas O; Almeda-Ortega J; Fernández-Vergel R; García-Campayo J; Luciano JV
BMC Fam Pract; 2016 Jun; 17():61. PubMed ID: 27245582
[TBL] [Abstract][Full Text] [Related]
17. Visceral pain as a triggering factor for fibromyalgia symptoms in comorbid patients.
Costantini R; Affaitati G; Wesselmann U; Czakanski P; Giamberardino MA
Pain; 2017 Oct; 158(10):1925-1937. PubMed ID: 28683025
[TBL] [Abstract][Full Text] [Related]
18. Patients' experiences of living with and receiving treatment for fibromyalgia syndrome: a qualitative study.
Lempp HK; Hatch SL; Carville SF; Choy EH
BMC Musculoskelet Disord; 2009 Oct; 10():124. PubMed ID: 19811630
[TBL] [Abstract][Full Text] [Related]
19. The German fibromyalgia consumer reports - a cross-sectional survey.
Häuser W; Jung E; Erbslöh-Möller B; Gesmann M; Kühn-Becker H; Petermann F; Langhorst J; Thoma R; Weiss T; Wolfe F; Winkelmann A
BMC Musculoskelet Disord; 2012 May; 13():74. PubMed ID: 22607517
[TBL] [Abstract][Full Text] [Related]
20. Duloxetine and pregabalin for pain management in multiple rheumatic diseases associated with fibromyalgia.
Angeletti C; Guetti C; Piroli A; Angeletti PM; Paladini A; Ciccozzi A; Marinangeli F; Varrassi G
Pain Pract; 2013 Nov; 13(8):657-62. PubMed ID: 23126475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
